Please assess the completion status of the following clinical trial:

Trial Title: Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Presence of trichiasis:~* no previous report of trichiasis surgery in at least one eye with trichiasis:~* Agreement by at least one other family member accompanying the patient that, if the patient is randomized to the family-treatment arm, s/he also would be willing to receive antibiotic treatment~* Age 18 or older~Exclusion Criteria:~* other household members concurrently participating in the trial~* Self-reported pregnancy~* Documented allergy to tetracycline~* Plans to move out of the region within 1 year.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: ACTIVE_COMPARATOR): topical tetracycline
- Intervention 1 (Type: ACTIVE_COMPARATOR): oral azithromycin, single 1g dose to subject
- Intervention 2 (Type: ACTIVE_COMPARATOR): single oral azithromycin dose to subject and immediate family members

Based on this trial design, predict the completion outcome and termination type (if applicable).